Subscribe
Subscribe
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
Logo IMG
HOME > MULTIMEDIA > Multimedia Detail

SCIENCE IN THE NEWS DAILY

New Take on a Prostate Drug, and a New Debate

from the New York Times (Registration Required)

For the first time, leading prostate cancer specialists say, they have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent.

But the discovery, arising from a new analysis of a large federal study, comes with a debate: Should men take the drug?

Prostate cancer is unlike any other because it is relatively slow-growing, and while it can kill, it often is not lethal. In fact, most leading specialists say, a major problem is that men are getting screened, discovering they have cancers that may or may not be dangerous, and opting for treatments that can leave them impotent or incontinent.

Read more...


comments powered by Disqus
 

EMAIL TO A FRIEND :

Subscribe to American Scientist